CLINICAL_TRIALS
trial_result
· 2014-05-05
Clinical Trial Update: Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension [Phase 3]
Summary
A Phase 3 trial evaluating macitentan in patients with symptomatic pulmonary arterial hypertension has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-05-05